文献速递青光眼

Rho相关蛋白激酶抑制剂诱导人小梁网VI型胶原形态学改变

Rho-associated protein kinase inhibitor induced morphological changes in type VI collagen in the human trabecular meshwork.
PubMed 文献 · Br J Ophthalmol · 2019-06-14

这项横断面研究纳入10例原发性开角型青光眼患者,比较使用或未使用利帕舒地尔滴眼液者小梁网VI型胶原的电子显微镜形态。结果显示用药组VI型胶原ORR宽度显著小于未用药组,IRR宽度显著大于未用药组,提示利帕舒地尔诱导了VI型胶原的形态学改变。

要点

  • 使用利帕舒地尔组ORR宽度为37.85±3.43 nm,显著小于未用药组的50.62±5.23 nm。
  • 使用利帕舒地尔组IRR宽度为70.68±10.84 nm,显著大于未用药组的58.19±5.34 nm。
  • VI型胶原总宽度的形态学改变与利帕舒地尔用药时长呈趋势相关(r=0.9,p=0.08)。

核心结论

  • 原发性开角型青光眼患者使用利帕舒地尔可诱导小梁网VI型胶原发生形态学改变。

研究设计与样本

  • 横断面研究,纳入2015年12月至2016年9月在东海大学八王子医院接受常规流出道重建术的原发性开角型青光眼患者(年龄60-80岁),共10只眼(每组5眼)。

主要发现

  • 使用利帕舒地尔组ORR宽度为37.85±3.43 nm,显著小于未使用组的50.62±5.23 nm(p<0.05)。
  • 使用利帕舒地尔组IRR宽度为70.68±10.84 nm,显著大于未使用组的58.19±5.34 nm(p<0.05)。
  • VI型胶原总宽度的形态学改变与利帕舒地尔用药时长呈趋势相关(r=0.9,p=0.08)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To investigate morphological changes in type VI collagen in the human trabecular meshwork associated with the rho kinase inhibitor ripasudil. METHODS: This cross-sectional study evaluated the effects of ripasudil eye drop administration (RA) or no ripasudil eye drop administration (NRA) in patients with primary open-angle glaucoma (POAG; age range 60-80 years) who underwent conventional outflow reconstruction between December 2015 and September 2016 at Tokai University Hachioji Hospital. The juxtacanalicular tissue was removed and imaged using transmission electron microscopy. Type VI collagen comprises cross-banded aggregates with transverse bands 30 nm apart repeating every 105 nm. The transverse bands are called the outer rod-like region (ORR) and the intervals are called the inner rod-like region (IRR). The waveform intensity in the type VI collagen was analysed in electron micrographs using Fourier transformation to detect the IRR and ORR borders. RESULTS: Ten eyes of 10 patients were included (n=5/group). The baseline characteristics did not differ significantly between groups. ORR width was significantly smaller in the RA group (37.85±3.43 nm) than in the NRA group (50.62±5.23 nm, p<0.05), whereas IRR width was significantly greater in the RA group (70.68±10.84 nm) than in the NRA group (58.19±5.34 nm, p<0.05). Morphological changes in the type VI collagen total width tended to correlate with the duration of ripasudil administration (r=0.9, p=0.08). CONCLUSIONS: Ripasudil administration in patients with POAG induced morphological changes in type VI collagen. Patients with POAG administered RA had a significantly smaller ORR width and a significantly greater IRR width than patients with POAG not administered RA.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Okamoto M, Nagahara M, Tajiri T, et al. Rho-associated protein kinase inhibitor induced morphological changes in type VI collagen in the human trabecular meshwork. Br J Ophthalmol. 2019. PMID: 31201167. doi:10.1136/bjophthalmol-2018-312991

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。